Peter Salgo, MD, and Bryan Loy, MD, discuss the focus of the 21st Century Cures Initiative recently launched by the US Congress and describe strategies to help promote innovation in medical oncology.
Dr Loy explains that the Initiative’s focus is to facilitate innovation by addressing various barriers that affect the development of new treatment options.
Because the Initiative is designed to allow various stakeholders in healthcare to share their opinions about how to accelerate the pace of healthcare innovation in the United States, a rapid acceleration in the pace of innovation is expected. However, Dr Loy notes the discussions required by the Initiative may be insufficient, and comments that conversations among various stakeholders regarding how to review and ultimately utilize newer treatment options are necessary.
During the drug development process, pharmaceutical companies are often concerned about regulatory and reimbursement risks. Dr Loy explains that adopting an approach in which risk is shared among various parties can help lower the costs associated with research.
Additionally, Dr Loy suggests that involving multiple stakeholders (including the FDA, payers, physicians, and patients) early in the clinical trial design process can help speed innovation and have a positive impact on patient care.
Watch our related Peer Exchange, Oncology Stakeholder Summit 2014: Evidence-Based Decisions to Improve Quality and Regulate Costs
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Medicaid, Medicare Policy Changes Could Lead to More Than 25,000 Additional Deaths, Study Says
April 30th 2024Researchers also estimated that more than 700,000 Americans with diabetes could lose insurance coverage if these proposed retractions are put into place, with some new policies already in effect.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen